HIGHLIGHTS
- who: Oskar W. Angenete MD from the The participants in this study constitute a subset of , children and adolescents selected from a prospective, longitudinal observational study addressing TMJ involvement in children with JIA (n=228), the Norwegian JIA Study (NorJIA), NCT number , in wwwclinicaltrials.gov. Participants in the NorJIA study were recruited from three tertiary pediatric university hospitals (Haukeland University hospital, Bergen, St Olav University hospital, Trondheim and University hospital of North Norway, Troms). Inclusion criteria were a diagnosis of JIA according to the ILAR criteria (25) performed by experienced pediatric rheumatologists, and age between , and , years . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.